259 related articles for article (PubMed ID: 33046156)
1. Recurrence rates in stable bipolar disorder patients after drug discontinuation
Kishi T; Matsuda Y; Sakuma K; Okuya M; Mishima K; Iwata N
Psychol Med; 2021 Nov; 51(15):2721-2729. PubMed ID: 33046156
[TBL] [Abstract][Full Text] [Related]
2. Effects of a conventional mood stabilizer alone or in combination with second-generation antipsychotics on recurrence rate and discontinuation rate in bipolar I disorder in the maintenance phase: A systematic review and meta-analysis of randomized, placebo-controlled trials.
Kishi T; Sakuma K; Okuya M; Matsuda Y; Esumi S; Hashimoto Y; Hatano M; Miyake N; Miura I; Mishima K; Iwata N
Bipolar Disord; 2021 Dec; 23(8):789-800. PubMed ID: 33561884
[TBL] [Abstract][Full Text] [Related]
3. Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials.
Kishi T; Ikuta T; Matsuda Y; Sakuma K; Okuya M; Mishima K; Iwata N
Mol Psychiatry; 2021 Aug; 26(8):4146-4157. PubMed ID: 33177610
[TBL] [Abstract][Full Text] [Related]
4. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of lithium and lamotrigine for the maintenance treatment of clinically stable patients with bipolar disorder: A systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials with an enrichment design.
Oya K; Sakuma K; Esumi S; Hashimoto Y; Hatano M; Matsuda Y; Matsui Y; Miyake N; Nomura I; Okuya M; Iwata N; Kato M; Hashimoto R; Mishima K; Watanabe N; Kishi T
Neuropsychopharmacol Rep; 2019 Sep; 39(3):241-246. PubMed ID: 31026388
[TBL] [Abstract][Full Text] [Related]
6. Recurrence of Mania or Depression Among Adult Bipolar Patients Who Continued Using Lithium: A Single-group Summary Meta-analysis of Randomized Trials.
Kishi T; Sakuma K; Okuya M; Matsuda Y; Esumi S; Hashimoto Y; Hatano M; Miyake N; Miura I; Miyahara K; Fujita K; Kawashima K; Mishima K; Iwata N
J Clin Psychopharmacol; 2020; 40(5):468-474. PubMed ID: 32701902
[TBL] [Abstract][Full Text] [Related]
7. Maintenance therapy with second generation antipsychotics for bipolar disorder - A systematic review and meta-analysis.
Lindström L; Lindström E; Nilsson M; Höistad M
J Affect Disord; 2017 Apr; 213():138-150. PubMed ID: 28222360
[TBL] [Abstract][Full Text] [Related]
8. Aripiprazole alone or in combination for acute mania.
Brown R; Taylor MJ; Geddes J
Cochrane Database Syst Rev; 2013 Dec; (12):CD005000. PubMed ID: 24346956
[TBL] [Abstract][Full Text] [Related]
9. Preventing new episodes of bipolar disorder in adults: Systematic review and meta-analysis of randomized controlled trials.
Nestsiarovich A; Gaudiot CES; Baldessarini RJ; Vieta E; Zhu Y; Tohen M
Eur Neuropsychopharmacol; 2022 Jan; 54():75-89. PubMed ID: 34489127
[TBL] [Abstract][Full Text] [Related]
10. Long-acting injectable antipsychotics (LAIs) for maintenance treatment of bipolar and schizoaffective disorders: A systematic review.
Pacchiarotti I; Tiihonen J; Kotzalidis GD; Verdolini N; Murru A; Goikolea JM; Valentí M; Aedo A; Vieta E
Eur Neuropsychopharmacol; 2019 Apr; 29(4):457-470. PubMed ID: 30770235
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of second generation antipsychotics in treating acute mixed episodes in bipolar disorder: a meta-analysis of placebo-controlled trials.
Muralidharan K; Ali M; Silveira LE; Bond DJ; Fountoulakis KN; Lam RW; Yatham LN
J Affect Disord; 2013 Sep; 150(2):408-14. PubMed ID: 23735211
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder.
Vieta E; Montgomery S; Sulaiman AH; Cordoba R; Huberlant B; Martinez L; Schreiner A
Eur Neuropsychopharmacol; 2012 Nov; 22(11):825-35. PubMed ID: 22503488
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials.
Smith LA; Cornelius V; Warnock A; Bell A; Young AH
Bipolar Disord; 2007 Jun; 9(4):394-412. PubMed ID: 17547586
[TBL] [Abstract][Full Text] [Related]
14. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
Macritchie KA; Geddes JR; Scott J; Haslam DR; Goodwin GM
Cochrane Database Syst Rev; 2001; (3):CD003196. PubMed ID: 11687047
[TBL] [Abstract][Full Text] [Related]
15. Number needed to treat analyses of drugs used for maintenance treatment of bipolar disorder.
Popovic D; Reinares M; Amann B; Salamero M; Vieta E
Psychopharmacology (Berl); 2011 Feb; 213(4):657-67. PubMed ID: 21052983
[TBL] [Abstract][Full Text] [Related]
16. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.
Bowden CL; Calabrese JR; Sachs G; Yatham LN; Asghar SA; Hompland M; Montgomery P; Earl N; Smoot TM; DeVeaugh-Geiss J;
Arch Gen Psychiatry; 2003 Apr; 60(4):392-400. PubMed ID: 12695317
[TBL] [Abstract][Full Text] [Related]
17. Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis.
De Hert M; Yu W; Detraux J; Sweers K; van Winkel R; Correll CU
CNS Drugs; 2012 Sep; 26(9):733-59. PubMed ID: 22900950
[TBL] [Abstract][Full Text] [Related]
18. A comparison of recurrence rates after discontinuation of second-generation antipsychotic long-acting injectable versus corresponding oral antipsychotic in the maintenance treatment of bipolar disorder: A systematic review.
Kishi T; Citrome L; Sakuma K; Iwata N
Psychiatry Res; 2024 Mar; 333():115761. PubMed ID: 38301289
[TBL] [Abstract][Full Text] [Related]
19. A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder.
Yatham LN
J Affect Disord; 2011 Jan; 128 Suppl 1():S21-8. PubMed ID: 21220077
[TBL] [Abstract][Full Text] [Related]
20. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
